- Question from Wells: Is it true that there is a national shortage of Adriamycin and if true, how does this happen?
- Answers - Eric Winer, M.D. There are some centers having trouble obtaining Adriamycin (chemical name: doxorubicin), but there is another drug, epirubicin, that can be substituted for it. It is not a problem we have had at our center, so it is quite variable around the country.
- Marisa Weiss The Adriamycin shortage is a national problem at many cancer centers right now. According to the FDA, shortages are due to increased demand and manufacturing delays.
The Ask-the-Expert Online Conference called Updates From the 2010 San Antonio Breast Cancer Symposium featured Eric Winer, M.D. and Marisa Weiss, M.D. answering your questions about the latest updates on breast cancer risk, screening, and treatment in early and metastatic breast cancer.
Editor's Note: This conference took place in December 2010.
The materials presented in these conferences do not necessarily reflect the views of Breastcancer.org. A qualified healthcare professional should be consulted before using any therapeutic product or regimen discussed. All readers should verify all information and data before employing any therapies described here.
A production of LiveWorld, Inc.
Copyright 2010. All rights reserved.